FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder

FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm617244.htm

Source: Food and Drug Administration - August 17, 2018 Category: American Health Source Type: news

More News: American Health | Food and Drug Administration (FDA) | Marketing | Obsessive Compulsive Disorder